Search

everythinglearnresearchcommunity

for

Search:↓

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Gene variation affects prostate issues and hair loss.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Minoxidil can reduce functions related to androgen receptors.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

Mice with human gene experienced hair loss when treated with DHT.